Publications by authors named "Kim Zerba"

Claim this Profile
B
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer.
Han Chang, Ariella Sasson, Sujaya Srinivasan, Ryan Golhar, Danielle M Greenawalt, Kim Zerba

Mol Diagn Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers.
Neal Ready, Matthew D Hellmann, Mark M Awad, Gregory A Otterson, Martin Gutierrez, Kim Zerba

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies.
Cory Batenchuk, Maher Albitar, Kim Zerba, Sucha Sudarsanam, Vladislav Chizhevsky

J Clin Pathol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer.
José Baselga, Milvia Zambetti, Antoni Llombart-Cussac, Georgy Manikhas, Ernst Kubista, Kim E Zerba

J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
Marc S Sabatine, Lynn Ploughman, Katy L Simonsen, Olga A Iakoubova, Todd G Kirchgessner, Kim E Zerba

Arterioscler Thromb Vasc Biol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS.
Olga A Iakoubova, Carmen H Tong, Anand P Chokkalingam, Charles M Rowland, Todd G Kirchgessner, Kim E Zerba

Arterioscler Thromb Vasc Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
Greetje J de Grooth, Kim E Zerba, Shu-Pang Huang, Zenta Tsuchihashi, Todd Kirchgessner

J Am Coll Cardiol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis